Click to read this document in English. DECATUR, Géorgie (États-Unis), le 1er mars 2022 /PRNewswire/ — Aujourd’hui, le Programme de Donation de Mectizan® (PDM)
Progress in eliminating onchocerciasis in the WHO Region of the Americas: disruption of ivermectin mass drug administration in the Yanomami focus area due to
Authors: Emily Toubali, Molly Brady, Ernest Mensah, Aryc Mosher, Emily Wainwright, Liz Eddy, Aria Gray, and Alyssa Jordan Multi-country experiences in implementing a direct
Progress report on the elimination of human onchocerciasis, 2018–2019. Weekly Epidemiological Record. WHO, 2019. Overview November 8, 2019 Onchocerciasis is a parasitic infection caused
Progress report on the elimination of human onchocerciasis, 2017–2018. Weekly Epidemiological Record. WHO, 2018 Overview Onchocerciasis, commonly known as “river blindness”, is a parasitic
WHO provides orientation webinars (with Joint Application packages provided in English, French, and Spanish versions at this link) for national program managers and partners
The Confirmatory Mapping Survey Builder tool was designed to provide a more rigorous assessment of ongoing lymphatic filariasis transmission where initial mapping yielded inconclusive
The TAS-STH Survey Sample Builder tool was designed to help capture the impact of lymphatic filariasis programs on soil-transmitted helminthiasis and provide guidance on
